BackOrion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) Overview
Orion Biotech Opportunities Corp - Units (1 Ord Share Class A & 1/5 War)

Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) P/E Ratio

Latest P/E ratio for Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War): 11.12 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

11.12

P/E Ratio

11.12

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) (ORIAU) FAQ

As of the most recent data, ORIAU shows a P/E ratio of 11.12. That is below the sector sector average of 25.13. Scroll down for historical charts and peer comparison views.

The its sector sector average P/E ratio is about 25.13. Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) is at 11.12, which is lower that average. That is roughly 55.7% below the sector mean. Use the comparison chart on this page to see how ORIAU stacks up against individual peers as well.

Investors watch ORIAU's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War)'s latest reading is 11.12. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this p/e ratio page, Stockcircle has Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 11.12) with ownership activity and broader fundamentals.